Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance

Go back to Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance

Horizon Pharma (HZNP) PT Raised to $39 at Cowen

November 6, 2019 10:05 AM EST

Cowen analyst Ken Cacciatore raised the price target on Horizon Pharma (NASDAQ: HZNP) to $39.00 (from $35.00) while maintaining a Outperform rating.

The analyst commented, "Horizon's Q3 was nicely above, with the key outperformance all due to the more durable orphan portfolio, which now... More